Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nutritional Evaluation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT05921968
What this trial is testing

Effect of Lactoferrin Versus Intravenous Iron Sucrose in Treatment of Anemia

Who this might be right for
Iron Deficiency Anemia
Ain Shams University 100
Not applicableUnknownNCT04080050
What this trial is testing

A Long-term Follow-up Study to Evaluate the Safety and Efficacy of RGX-501

Who this might be right for
Homozygous Familial Hypercholesterolemia (HoFH)
REGENXBIO Inc. 8
Not applicableUnknownNCT02487888
What this trial is testing

The Impact of Genetic Testing on Clinical Decision Making and Patient Care

Who this might be right for
PainChronic PainMental Disorders+3 more
Proove Bioscience, Inc. 100,000
Large-scale testing (Phase 3)Study completedNCT02648360
What this trial is testing

Text Messaging for Physical Activity & Healthy Eating

Who this might be right for
Overweight
University of Miami 12
Early research (Phase 1)Study completedNCT03063580
What this trial is testing

Effect of Rifampicin on the Pharmacokinetics and Pharmacodynamics of Sotagliflozin

Who this might be right for
Diabetes Mellitus
Sanofi 16
Early research (Phase 1)Study completedNCT01013766
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK1362885 in Type 2 Diabetics

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 23
Post-approval studies (Phase 4)Study completedNCT02984982
What this trial is testing

Evaluation of Effect of Alirocumab on Coronary Atheroma Volume in Japanese Patients Hospitalized for Acute Coronary Syndrome With Hypercholesterolemia

Who this might be right for
HypercholesterolemiaAcute Coronary Syndrome
Sanofi 206
Not applicableStudy completedNCT04227379
What this trial is testing

Diabetes Disparities: Texting to Extend Treatment (DD-TXT)

Who this might be right for
Diabetes Mellitus, Type 2
VA Office of Research and Development 366
Not applicableStudy completedNCT01934673
What this trial is testing

A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Patients With Type 2 Diabetes in Malaysia

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 1,668
Testing effectiveness (Phase 2)WithdrawnNCT03794973
What this trial is testing

Diabetes Autoimmunity Withdrawn in New Onset Patients (DAWN)

Who this might be right for
Diabetes Mellitus, Type 1
Tolerion, Inc.
Not applicableStudy completedNCT06666205
What this trial is testing

Carbohydrate Quality and Its Impact on Sleep and Depression in Type 2 Diabetes

Who this might be right for
Type 2 DM
Ankara Yildirim Beyazıt University 150
Not applicableStudy completedNCT04340648
What this trial is testing

Measurement Algorithm Control, Optimization, and Performance Evaluation of the Vital USA GlucoseDetect

Who this might be right for
Diabetes Mellitus
Sciema UG 32
Not applicableStudy completedNCT07013305
What this trial is testing

Pre- and Post-Treatment Investigation of B12 and Folic Acid (Folate) Levels in Patients Receiving Antiepileptic (Anticonvulsant) Treatment for Fibromyalgia: Retrospective Study

Who this might be right for
Fibromyalgia (FM)Vitamin B 12 DeficiencyFolic Acid Deficiency
Gaziosmanpasa Research and Education Hospital 104
Testing effectiveness (Phase 2)Study completedNCT00562575
What this trial is testing

Evaluation of Safety and Effects of SLx-4090 After Dosing for 14 Days in Subjects With High Triglycerides

Who this might be right for
Hypertriglyceridemia
Response Pharmaceuticals 24
Testing effectiveness (Phase 2)Study completedNCT05295875
What this trial is testing

Efficacy and Safety of ALT-801 in the Treatment of Obesity

Who this might be right for
Obesity/Overweight
Altimmune, Inc. 391
Testing effectiveness (Phase 2)Study completedNCT03815812
What this trial is testing

Multiple Ascending Dose Study of PCSK-9 Inhibitor (IBI306) in Chinese Patients With Hypercholesterolemia

Who this might be right for
Hypercholesterolemia
Innovent Biologics (Suzhou) Co. Ltd. 60
Not applicableStudy completedNCT02246400
What this trial is testing

CardioMetabolic Program Meets eHealth: Redesign and Evaluation for Optimal Reach and Impact

Who this might be right for
ObesityMetabolic SyndromePre-diabetes+2 more
Palo Alto Medical Foundation 74
Not applicableActive Not RecruitingNCT03076034
What this trial is testing

Utility of Cortical Bone Tissue Properties in the Assessment of Fracture Risk

Who this might be right for
Distal Radius FractureOsteoporosisHip Fractures
Beth Israel Deaconess Medical Center 190
Large-scale testing (Phase 3)Ended earlyNCT00449605
What this trial is testing

A Glycemic Control Evaluation of Glimepiride Versus Rimonabant on Top of Metformin in Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 508
Not applicableStudy completedNCT04974112
What this trial is testing

Multi-center Dynamic Investigation and Research on Nutritional Status of Inpatients

Who this might be right for
Nutrition
Second Affiliated Hospital, Zhejiang University, School of Medicine 3,000
Next Page